Corporate governance

Experience

Berkshire Partners LLC

• Advisory Director (since 2016)

Pall Corporation

• Chairman (2013 – 2015)
• Chief Executive Officer (2011 – 2015)

IDEX Corporation

• Chief Executive Officer (2005 – 2011)
• Chief Operating Officer (2004 – 2005)

Danaher Corporation

• Corporate Vice President and Group Executive (March 2004 – August 2004)
• President of Industrial Controls Group (2002 – 2004)
• President of Motion Group, Special Purpose Systems (2001 – 2002)

Qualifications

• Executive Leadership: Substantial experience leading high-technology, high-growth, multinational public companies as Chief Executive Officer of Pall Corporation, a global supplier of filtration, separations and purification products, and IDEX Corporation, a company specializing in fluid and metering technologies.Corporate Strategy: Significant experience guiding strategy and transformation in various public company senior executive positions and on numerous public company boards of directors.
• Corporate Strategy: Significant experience guiding strategy and transformation in various public company senior executive positions and on numerous public company boards of directors.
• Operations: Extensive experience overseeing complex business operations, including operational, manufacturing, supply chain and commercial activities, developed over his extensive career as a senior executive at Pall Corporation, IDEX Corporation and Danaher Corporation. 
• Mr. Kingsley also brings significant international business, financial acumen, corporate governance, human capital management, corporate finance and risk oversight skills and experience to the Board.

Education

• BS, Industrial Engineering and Management, Clarkson University
• MBA, College of William and Mary

Experience

Campbell Soup Company

• President/Divisional CEO, Pepperidge Farm Ltd. (2012 – 2015)
• Senior Vice President, Global Baking and Snacking (2012 – 2015)
• Senior Vice President and Chief Strategy Officer (2010 – 2012)
• President, Foodservice, North America (2008 – 2010)
• Vice President and General Manager, Sauces and Beverages (2005 – 2008)

Kraft Foods, Inc.

• Senior Vice President and General Manager, Salted Snacks (2004 – 2005)
• Vice President, Snacks (2001 – 2004)
• Vice President and Leader, Biscuits and Snacks, Canada (2000 – 2001)

Qualifications

• Human Capital Management: Deep understanding of human capital management and executive compensation matters gained through her general management roles, including as President/Divisional CEO of Pepperidge Farm, and her extensive public company board experience, including service as chair of human capital and compensation committees. 
• Operations: Experience managing the business operations at complex organizations, including operational, manufacturing, supply chain and commercial activities, developed through senior executive operational roles at Campbell Soup Company and Kraft Foods, Inc.  
• Corporate Strategy: Experience developing and implementing corporate strategy in the highly competitive food and snack industry in her numerous leadership roles at Campbell Soup Company and Kraft Foods, Inc.
• Ms. Chang Britt also brings significant executive leadership, financial acumen, corporate governance, innovation and R&D, international business, digital, corporate finance and risk oversight skills and experience to the Board.

Education

• BA, Anthropology, University of Toronto
• MBA, University of Western Ontario

Experience

3Com Corporation

• President, Chief Executive Officer, and member of the board of directors (January 2001 – 2006)
• President, Chief Operating Officer (August 1998 – January 2001)

Digital Equipment Corporation

• Senior Vice President, Sales and Marketing (1997 – 1998)
• Vice President and General Manager, PC Business Unit (1995 – 1997)

International Business Machines Corporation (IBM)

• Various senior management and executive positions (1973 – 1995)

Qualifications

• International Business: Experience engaging in international business transactions during his time as President and Chief Executive Officer of 3Com Corporation, a then public company that provided global computer networking solutions, which was acquired by Hewlett-Packard in 2010, where he established a joint venture in China in partnership with a leading Chinese global telecom solutions provider and at IBM where he lived and worked in Hong Kong and Tokyo and was responsible for IBM’s Asia/South Pacific Area.
• Digital: Deep understanding of advanced technology and how it may be utilized to further our corporate strategies and objectives, gained from his senior executive and outside public company roles at other high-technology companies.
• Corporate Strategy: Substantial experience developing, executing and overseeing corporate strategy at high-technology companies, including during his tenures as Chief Operating Officer and Chief Executive Officer of 3Com Corporation and serving on the boards of other public companies in the high-technology industry.
• Mr. Claflin also brings significant executive leadership, corporate governance, financial acumen, human capital management, innovation and R&D, operations, corporate finance and risk oversight skills and experience to the Board.

Education

• BA, Political Science, Pennsylvania State University

Experience

Integra LifeSciences Holdings Corporation

• Non-Executive Chair of Board of Directors (June 2012 – February 2024; since July 2025)
• Executive Chair of Board of Directors (January 2012 – June 2012; February 2024 – June 2025)
• Member of Board of Directors (since 1997)
• Chief Executive Officer (1997 – 2012)

Prettybrook Partners LLC

• Managing Director (since 2012)

Wellington Partners Advisory AG

• Venture Partner (since 2013)

TowerBrook Capital Partners

• Senior Advisor (2010 - 2025)

Goldman, Sachs and Co.

• Managing Director, M&A, specializing in the medical device, pharmaceutical and biotechnology sectors (1987 – 1997)

Qualifications

• Executive Leadership: Extensive executive management experience and deep strategic expertise in the global healthcare industry gained from over twenty-five years of experience in developing, executing and overseeing the corporate strategy of Integra LifeSciences Holdings Corporation, a manufacturer of medical devices used in neurosurgery and orthopedic surgery, as its Chief Executive Officer for fifteen years and board chair since 2012, during which time revenues increased over 100-fold.
• Corporate Strategy: Substantial experience in developing, assessing, executing and overseeing corporate strategy in the global healthcare industry acquired over the course of his career in various roles, including through his tenure as the Chief Executive Officer of Integra LifeSciences and significant outside board service, as well as his investment banking, venture capital and private equity firm experiences.
• Corporate Finance: Deep knowledge of capital markets, investment banking, and mergers and acquisitions acquired throughout the course of his career in investment banking, during which he specialized in the medical device, pharmaceutical and biotechnology sectors, and applied throughout his career at Integra LifeSciences and his outside board service.
• Dr. Essig also brings significant corporate governance, innovation and R&D, human capital management, financial acumen, international business, operations and risk oversight skills and experience to the Board. 

Education

• BA, School of Public and International Affairs at Princeton University
• MBA, University of Chicago
• PhD, Financial Economics, University of Chicago

Experience

State Street Corporation

• Board Chair (2011 – 2019)
• Chief Executive Officer (2010 – 2018)
• President and Chief Operating Officer (2008 – 2014)
• Executive Vice President and Head of Investor Services Division (2002 – 2008)
• Vice Chairman and Global Business Experience Head of Investment Servicing and Investment Research and Trading (2006)

Boston Financial Data Services

• President and Chief Executive Officer (1990 – 2000)

National Financial Data Services

• President and Chief Executive Officer (1988 – 1990)

Qualifications

• Executive Leadership: Extensive executive leadership and management experience gained in roles of increasing seniority in the global financial services industry, including as Board Chair and Chief Executive Officer of State Street, during which time he oversaw the servicing of over $35 trillion of assets and the stewardship of over $4 trillion in capital.
• Corporate Governance: Substantial experience with corporate governance gained from public company board experience and as a public company executive leading State Street. Mr. Hooley’s unique background gives him deeper insight into institutional investors’ points of view and ensures those perspectives are incorporated into Board discussions with management.
• Corporate Strategy: Deep experience in developing, executing and overseeing corporate strategy in the global financial services industry. To that end, as Board Chair and Chief Executive Officer of State Street, Mr. Hooley led the organization through a period of global growth and technological transformation and helped it navigate the post-financial crisis of 2008.
• Mr. Hooley also brings significant financial acumen, international business, operations, corporate finance, digital, innovation and R&D, risk oversight and human capital management skills and experience to the Board.

Experience

ImmunoGen, Inc.

• President and Chief Executive Officer (2009 – 2016)
• President and Chief Operating Officer and Acting Chief Financial Officer (July 2008 - December 2008)
• Executive Vice President and Chief Financial Officer (2006 – 2008)
• Senior Vice President and Chief Financial Officer (2005 – 2006)

New England Business Service, Inc.

• Executive Vice President and Chief Financial Officer (2002 – 2004)
• Senior Vice President and Chief Financial Officer (1998 – 2002)

Nashua Corporation

• Vice President and Chief Financial Officer (1996 – 1998)
• Joined in 1984 and held various financial management positions of increasing responsibility

Qualifications

• Financial Acumen: Extensive knowledge and experience in the review and preparation of financial statements and a strong understanding of complex financial and accounting topics, internal controls over financial reporting, and financial planning developed over the course of his almost twenty-five years serving in various financial management roles, including more than a decade as the chief financial officer of various companies.
• Executive Leadership: Substantial executive leadership experience gained from serving as the Chief Executive Officer of ImmunoGen, Inc., a then public biotechnology company, which was acquired by AbbVie Inc. in February 2024, that developed targeted anticancer therapeutics, where he was credited with successfully building integrated research, clinical, regulatory and manufacturing functions at the company and expanding its technology portfolio significantly.
• Corporate Strategy: Deep experience as displayed while at ImmunoGen, Inc., where under his leadership the company transformed from being a research-focused company to one with strong clinical development and manufacturing capabilities.
• Mr. Junius also brings significant corporate governance, human capital management, innovation and R&D, operations, risk oversight and corporate finance skills and experience to the Board.

Education

• BA, Political Science, Boston College

Experience

IDEXX

• President and CEO (since October 2019)
• Interim President and CEO (June 2019 – October 2019)
• Executive Vice President (August 2012 – June 2019)

Philips Healthcare, a subsidiary of Royal Philips Electronics (now named Royal Philips)

• Senior Vice President and General Manager, Computed Tomography, Nuclear Medicine and Radiation Therapy Planning (2010 – 2012)
• Various roles of increasing responsibility (2001 – 2010)

Agilent Technologies (acquired by Royal Philips Electronics in 2001)

• Executive in Charge, Agilent Healthcare Solutions Group divestiture (2000 – 2002)
• General Manager, Medical Consumables Business Unit (1997 – 2000)

Hewlett Packard

• Various roles in finance, marketing and business planning (1988 – 1996)

Qualifications

• Executive Leadership: Extensive leadership and management experience gained during his time in various roles at IDEXX, including as President and CEO during which time he has prioritized innovation, built expanded commercial capabilities and scaled our warehouse, distribution and manufacturing capabilities to support continued growth, and as Executive Vice President, where he was responsible for the North American Companion Animal Group Commercial Organization and key elements of the innovation portfolio, including IDEXX VetLab in-house diagnostics, Diagnostic Imaging, Veterinary Software and Services, Rapid Assay and Telemedicine lines of business.
• Corporate Strategy: Deep experience developing and implementing strategies for continued long-term sustainable growth at IDEXX, including transforming our go-to-market strategy in North America in 2014, significant international commercial expansions, investments in innovation and an emphasis on delivering a differentiated customer experience.
• Innovation and R&D: Substantial experience leading organizations to create innovative, integrated healthcare solutions that improve the standard of care, including at Philips Healthcare and IDEXX; as President and CEO of IDEXX, he has prioritized investment in (and focus on) intelligent innovation, resulting in the introduction of multiple customer-centric products and services that will advance pet healthcare, including IDEXX Cancer Dx (a first-of-its-kind diagnostic panel that detects canine lymphoma), IDEXX inVue Dx Cellular Analyzer (a slide-free instrument that assesses cells in their natural state) and Vello (a pet-owner engagement software solution).
• Mr. Mazelsky also brings significant corporate governance, financial acumen, human capital management, international business, digital, corporate finance (including mergers and acquisitions), operations, sustainability and risk oversight skills and experience to the Board.

Education

• BA, Mathematics, University of Rochester
• MBA, University of Chicago Booth School of Business

Experience

Intercom, Inc.

• Board advisor (2022-2023)
• Chief Executive Officer (2020 – 2022)
• Chief Operating Officer (2017 – 2020)

Intuit Inc.

• Senior Vice President, Small Business (2016 – 2017)
• General Manager, Employee Management Solutions division (2014 – 2016)
• Vice President, Product Management and Marketing (2011 – 2014)
• Other senior roles of increasing responsibility (2002 – 2011)

Qualifications

• Executive Leadership: Substantial executive leadership experience gained from over five years in COO and CEO positions at Intercom, Inc., a customer service platform and leader in AI, during which time revenue increased 5-fold and the company achieved profitability. Prior to that, Ms. Peacock helped build one of the world’s biggest SaaS businesses and ultimately as SVP, led Intuit’s largest reportable segment with $3B in revenue.
• Digital: As a seasoned executive with experience building and running software and technology businesses at various lifecycle stages, overseeing cloud-based product launches, and serving as a board member of Dropbox, a global collaboration platform provider, Ms. Peacock brings substantial B2B, SaaS software and AI experience to our Board.
• Operations: Ms. Peacock brings significant experience managing complex business operations through her many senior roles at Intuit, including leading its Small Business segment, responsible for moving over $300B on behalf of customers each year, as well as in her capacity as COO and then CEO of Intercom.
• Ms. Peacock also brings valuable corporate governance, corporate strategy, risk oversight, innovation and R&D, human capital management and international business experience to our Board.

Education

• BA, Applied Mathematics, Harvard University
• MBA, Stanford Graduate School of Business

Experience

Quest Diagnostics Incorporated

• Executive Vice President and Chief Financial Officer (since July 2022)

Illumina, Inc.

• Senior Vice President and Chief Financial Officer (January 2017 – July 2022)

Cardinal Health, Inc.

• Senior Vice President and Corporate Treasurer (February 2012 – January 2017)
• Senior Vice President and Chief Financial Officer, Pharmaceutical Segment (2009 – 2012)
• Vice President, Healthcare Supply Chain Services (2007 – 2009)

Other Experiences

• Various finance roles at Eli Lily and Company and PepsiCo, Inc.

Qualifications

• Financial Acumen: Substantial experience in the review and preparation of financial statements and a strong understanding of complex financial and accounting topics, internal controls over financial reporting and financial planning, gained through his current role as Chief Financial Officer of Quest Diagnostics Incorporated and prior role at Illumina, Inc.
• Corporate Finance: Deep experience and knowledge in matters of corporate finance, including capital market transactions and mergers and acquisitions, developed during his long career holding roles of increasing responsibility in the finance field.
• International Business: Extensive international operational experience, including during his tenure at Cardinal Health where he had significant leadership responsibility for the China business operations. 
• Mr. Samad also brings significant executive leadership, corporate governance, corporate strategy, innovation and R&D, digital, human capital management, operations, sustainability and risk oversight skills and experience to the Board. 

Education

• Bachelor’s Degree in Business Administration (BBA), American University of Beirut
• MBA, McMaster University

Experience

Szostak Partners

• Founder, President (since 2004)

Fleet/Boston Financial Group (now Bank of America)

• Board Chair and Chief Executive Officer, Fleet Bank-Rhode Island (2001 – 2003)
• Corporate Executive Vice President and Chief Human Resources Officer, FleetBoston Financial Group (1998 – 2004)
• Board Chair, President and Chief Executive Officer, Fleet-Maine (1991 – 1994)

Qualifications

• Executive Leadership: Substantial executive leadership experience gained from her roles at Fleet/Boston Financial Group, including serving as the Chief Executive Officer of two major bank subsidiaries, as well as through completion of several executive education programs at Harvard Business School.
• Corporate Governance: Extensive experience with corporate governance gained from substantial public company board experience and service as board chair and chief executive officer of two major bank subsidiaries. 
• Human Capital Management: Deep experience with human capital management matters, including executive succession planning, which is within the purview of our Governance and Corporate Responsibility Committee, gained from her CEO experience and long history of human resources leadership, including during her tenure as Chief Human Resources Officer at Fleet/Boston Financial Group.
• Ms. Szostak also brings significant financial acumen, corporate strategy, international business, operations, corporate finance and risk oversight skills and experience to the Board. 

Education

• BA, Sociology, Colby College

Experience

Strategic Vision Ventures LLC

• Founder and owner (since February 2021)

Massachusetts Institute of Technology School of Engineering

• Inaugural Visiting Scholar (2019 – 2020 academic year)

International Business Machines Corporation

• Vice President, Emerging Technology Partnerships (August 2018 – August 2019)
• Chief Operating Officer, IBM Research (January 2017 – August 2018)

Xerox Corporation

• Chief Technology Officer and Corporate Vice President, Xerox Corporation (2006 – 2016)
• President, Xerox Innovation Group (2006 – 2016)
• Chief Engineer, Xerox Corporation (2002 – 2005)
• Oversaw Xerox’s global research centers, including the Palo Alto Research Center

Other Experience

• Dr. Vandebroek is the Chair of the Advisory Committee of the Flanders AI Research Program, a member of the AI Innovation Board of the Norwegian Research Center for AI, a Fellow of the Institute of Electrical & Electronics Engineers and was appointed an honorary Professor at KU Leuven, Belgium in 2021.

Qualifications

• Innovation and R&D: Long track record of innovation and experience managing balanced research and development portfolios at IBM and Xerox Corporation.
• Digital: Deep experience and knowledge in information technology and cybersecurity, including overseeing significant information technology projects to facilitate business objectives, developed over the course of over twenty years serving in various senior executive roles at IBM and Xerox Corporation.
• Sustainability: Substantial knowledge of and experience overseeing sustainability issues gained from her global outside private and public company board service.
• Dr. Vandebroek also brings executive leadership, financial acumen, corporate governance, corporate strategy, operations, international business, human capital management and risk oversight skills and experience to the Board.

Education

• BS, Engineering, KU Leuven
• MS, Electro-mechanical Engineering, KU Leuven
• PhD, Electrical Engineering, Cornell University